Table 3 CV comorbidities in individuals with T2D covered by the study and inter-practice variation
N (%) | Minimum–maximum range | Median (IQR) | |
|---|---|---|---|
Individuals with T2D in the study | 23,036 (100.0) | 15—370 | 133 (95—179) |
with associated arterial hypertension | 13,493 (58.6) | 0—180 | 80 (50—100) |
with associated CAD | 4,622 (20.0) | 0—92 | 22 (10—40) |
with associated CKD (eGFR < 60 mL/min) | 4,001 (17.4) | 0—90 | 20 (10—34) |
with associated acute HF in the last year | 1,164 (5.0) | 0—50 | 4 (2—8) |